SB 202190

(HB1301)

Product overview

  • Name
    SB 202190
  • Short description
    Potent ATP competitive p38 MAPK inhibitor
  • Biological description
    Potent ATP competitive p38 MAPK inhibitor (IC50 values are 50 and 100 nM for p38α and p38β respectively). Inhibits TNF, IL-1 and CK1 (approx IC50 = 0.6 μM) therefore inhibits CREB phosphorylation. Exhibits little or no activity at CK2. Displays anti-inflammatory properties and induces apoptosis.
  • Alternative names
    SB-202190
  • Biological action
    Inhibitor
  • Purity
    >99%
  • Our products in action

Properties

  • Chemical name
    4-[4-(4-Fluorophenyl)-5-(4-pyridiny l)-1H-imidazol-2-yl]phenol
  • Molecular Weight
    331.35
  • Chemical structure
    SB 202190  [152121-30-7]
  • Molecular Formula
    C20H14N3OF
  • CAS Number
    152121-30-7

Storing and Using Your Product

  • Storage instructions
    -20°C
  • Solubility overview
    soluble in DMSO (100mM)

References for SB 202190

  • Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190.

    Shanware NP et al (2009) BMB Rep 42(3) : 142-7.
    PubMedID: 19336000
  • Specificity and mechanism of action of some commonly used protein kinase inhibitors.

    Davies SP et al (2000) Biochem J 351(Pt 1) : 95-105.
    PubMedID: 10998351
  • Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase.

    Nemoto S et al (1998) J Biol Chem 273(26) : 16415-20.
    PubMedID: 9632706

Reviews & Product Guides